Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 ...
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...
Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ) has shared an announcement. Tribeca Global Natural Resources Limited has provided an updated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results